CareLit · DOI-Nachweis · Nuklearmedizin - NuclearMedicine
FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT
DOI 10.1055/a-2185-7746
Bibliografische Angaben
Nachweis in CareLit
Autor:innenShaghayegh Nourbakhsh, Yalda Salehi, Saeed Farzanehfar, Reza Ghaletaki, Mohsen Bakhshi Kashi, Mehrshad Abbasi
ZeitschriftNuklearmedizin - NuclearMedicine
Ausgabe03/2025
Jahrgang / SeitenJg. 64 · S. 188-192
Kernaussage aus der Literatur
Abstract-Vorschau
Abstract Purpose The role of fibroblast activation protein inhibitor (FAPI) PET CT scan is not well documented in papillary thyroid cancer (PTC) patients. Patients with radioiodine refractory PTC and high thyroglobulin levels need PET/CT scan which is generally done by 18F FDG. In the current study, the diagnostic performance of 68Ga FAPI and FDG PET/CT scans were compared head to head in patients with radioiodine r…
Zitieren
Zitierempfehlung
Shaghayegh Nourbakhsh, Yalda Salehi, Saeed Farzanehfar, Reza Ghaletaki, Mohsen Bakhshi Kashi, Mehrshad Abbasi (2025) FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT. Nuklearmedizin - NuclearMedicine, 64 (03), 188-192. https://doi.org/10.1055/a-2185-7746
Mit CareLit weiterarbeiten